Cris De Luca is a Partner at Sanofi Ventures, the corporate venture capital arm of Sanofi. See sector focus and contact routes.
Cris De Luca is a Partner at Sanofi Ventures, the corporate venture capital arm of Sanofi, where he joined in 2020 to lead investments in digital health and artificial intelligence. His investment thesis targets early-stage and growth-stage companies globally, with a specific focus on digital health, AI, data science, computational biology, and drug discovery. De Luca typically invests between $5.0 million and $10.0 million, with a sweet spot around $7.5 million, and serves as a board member or board observer for his investments. Notable portfolio companies where he holds board positions include Empatica, Nucleai, Medisafe, Click Therapeutics, and Carbon Health. He also serves as a board observer at Omada Health and Aetion. While De Luca co-founded Ultra Light Startups, a major venture pitch accelerator, and was named to the Boston Business Journal’s 40 Under 40 list, the search results do not contain specific public writing or a distinctive published point of view beyond his firm’s stated focus on transforming medical practice and helping patients.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Cambridge.
Investors like Cris De Luca · Full investor directory · Investor access · Company funding database